Staphylococcus aureus from atopic dermatitis skin alters cytokine production triggered by monocyte-derived Langerhans cell. 2017

Kazumasa Iwamoto, and Masaya Moriwaki, and Yoshie Niitsu, and Masachika Saino, and Shunsuke Takahagi, and Junzo Hisatsune, and Motoyuki Sugai, and Michihiro Hide
Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.

BACKGROUND Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases. The skin of patients with AD presents as a disbalance of the microbiome with a strong colonization by Staphylococcus aureus, which positively correlates with the severity of the disease. However, the effect of colonized S. aureus on the skin immune system has not been fully elucidated. OBJECTIVE The aim of this study is to explore whether S. aureus isolated from AD skin is able to skew T cell responses via Langerhans cells (LC) as compared to a standard strain of S. aureus and S. epidermidis. METHODS We prepared monocyte-derived LC (MoLC) from healthy controls and patients with AD, and stimulated MoLC with a standard strain of S. aureus NCTC8325, S. aureus TF3378 isolated from AD skin, or S. epidermidis. Stimulated MoLC were co-cultured with autologous CD4pos T cells and then T cell responses were analyzed by T cell polarization assays, cytokine analysis and real-time PCR. RESULTS MoLC stimulated by S. aureus TF3378 induced significantly high and rapid proliferation of T cells as compared to those by S. aureus NCTC8325 and S. epidermidis. Cytokine productions from T cells cultured with S. aureus TF3378-stimulated MoLC showed significantly high amounts of IL-2 and less IFN-γ production with imbalanced Th1/Th2 (decreased TBX21/GATA3 ratio) mRNA expression. The T cell proliferation with increased IL-2 production via S. aureus TF3378-stimulated MoLC was diminished by treatment of proteinase K. CONCLUSIONS S. aureus TF3378 on AD skin can skew T cell responses via LC toward imbalanced Th1/Th2 skin immunity.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007801 Langerhans Cells Recirculating, dendritic, antigen-presenting cells containing characteristic racket-shaped granules (Birbeck granules). They are found principally in the stratum spinosum of the EPIDERMIS and are rich in Class II MAJOR HISTOCOMPATIBILITY COMPLEX molecules. Langerhans cells were the first dendritic cell to be described and have been a model of study for other dendritic cells (DCs), especially other migrating DCs such as dermal DCs and INTERSTITIAL DENDRITIC CELLS. Langerhans Cell,Dendritic Cells, Dermal,Dendritic Cells, Epidermal,Dendritic Cells, Skin,Dermal Dendritic Cells,Epidermal Dendritic Cells,Skin Dendritic Cells,Cell, Dermal Dendritic,Cell, Epidermal Dendritic,Cell, Langerhans,Cell, Skin Dendritic,Cells, Dermal Dendritic,Cells, Epidermal Dendritic,Cells, Langerhans,Cells, Skin Dendritic,Dendritic Cell, Dermal,Dendritic Cell, Epidermal,Dendritic Cell, Skin,Dermal Dendritic Cell,Epidermal Dendritic Cell,Skin Dendritic Cell
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003876 Dermatitis, Atopic A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. Eczema, Atopic,Eczema, Infantile,Neurodermatitis, Atopic,Neurodermatitis, Disseminated,Atopic Dermatitis,Atopic Eczema,Atopic Neurodermatitis,Disseminated Neurodermatitis,Infantile Eczema
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.

Related Publications

Kazumasa Iwamoto, and Masaya Moriwaki, and Yoshie Niitsu, and Masachika Saino, and Shunsuke Takahagi, and Junzo Hisatsune, and Motoyuki Sugai, and Michihiro Hide
March 2011, Allergy,
Kazumasa Iwamoto, and Masaya Moriwaki, and Yoshie Niitsu, and Masachika Saino, and Shunsuke Takahagi, and Junzo Hisatsune, and Motoyuki Sugai, and Michihiro Hide
January 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
Kazumasa Iwamoto, and Masaya Moriwaki, and Yoshie Niitsu, and Masachika Saino, and Shunsuke Takahagi, and Junzo Hisatsune, and Motoyuki Sugai, and Michihiro Hide
January 1985, Dermatologica,
Kazumasa Iwamoto, and Masaya Moriwaki, and Yoshie Niitsu, and Masachika Saino, and Shunsuke Takahagi, and Junzo Hisatsune, and Motoyuki Sugai, and Michihiro Hide
January 2024, Journal of dermatological science,
Kazumasa Iwamoto, and Masaya Moriwaki, and Yoshie Niitsu, and Masachika Saino, and Shunsuke Takahagi, and Junzo Hisatsune, and Motoyuki Sugai, and Michihiro Hide
January 1996, Dermatology (Basel, Switzerland),
Kazumasa Iwamoto, and Masaya Moriwaki, and Yoshie Niitsu, and Masachika Saino, and Shunsuke Takahagi, and Junzo Hisatsune, and Motoyuki Sugai, and Michihiro Hide
January 2004, Medicinski arhiv,
Kazumasa Iwamoto, and Masaya Moriwaki, and Yoshie Niitsu, and Masachika Saino, and Shunsuke Takahagi, and Junzo Hisatsune, and Motoyuki Sugai, and Michihiro Hide
October 1983, Archives of dermatology,
Kazumasa Iwamoto, and Masaya Moriwaki, and Yoshie Niitsu, and Masachika Saino, and Shunsuke Takahagi, and Junzo Hisatsune, and Motoyuki Sugai, and Michihiro Hide
November 1985, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
Kazumasa Iwamoto, and Masaya Moriwaki, and Yoshie Niitsu, and Masachika Saino, and Shunsuke Takahagi, and Junzo Hisatsune, and Motoyuki Sugai, and Michihiro Hide
January 2005, Clinical and experimental dermatology,
Kazumasa Iwamoto, and Masaya Moriwaki, and Yoshie Niitsu, and Masachika Saino, and Shunsuke Takahagi, and Junzo Hisatsune, and Motoyuki Sugai, and Michihiro Hide
January 2022, Arerugi = [Allergy],
Copied contents to your clipboard!